Table 4 |
||||
|
The adverse events. |
||||
|
Patient number |
Occurrence number |
p-value |
||
|
n (%) |
N |
|||
|
|
||||
|
Adverse Event |
Exp. |
19 (54.3) |
42 |
0.35 |
|
Cont. |
16 (43.2) |
26 |
χ2-test |
|
|
Sum |
35 (48.6) |
68 |
||
|
|
||||
|
Adverse Drug Reaction |
Exp. |
9 (25.7) |
12 |
0.19 |
|
Cont. |
5 (13.5) |
8 |
χ2-test |
|
|
Sum |
14 (19.4) |
20 |
||
|
|
||||
|
Severe Adverse Event |
Exp. |
1 (2.9) |
1 |
0.49 |
|
Cont. |
0 (0.0) |
0 |
Exact test |
|
|
Sum |
1 (1.4) |
1 |
||
|
|
||||
|
Kim et al. BMC Musculoskeletal Disorders 2009 10:20 doi:10.1186/1471-2474-10-20 |
||||
